- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Efficacy of a second line luteinizing hormone-releasing hormone agonist after advanced prostate cancer biochemical recurrence - Abstract
February 21, 2011
Real-time elastography in the diagnosis of prostate cancer: Personal experience - Abstract
February 18, 2011
Intermittent androgen suppression in prostate cancer: Testosterone levels and its implication - Abstract
February 18, 2011
Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer - Abstract
February 18, 2011
Significance of serum testosterone for prostate-specific antigen (PSA) elevation and prediction of prostate cancer in patients with PSA above 10 ng/ml - Abstract
February 17, 2011
Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: Implications for chemoprevention of prostate cancer - Abstract
February 17, 2011
Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: Autocrine effects on cell proliferation and migration - Abstract
February 17, 2011
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo - Abstract
February 17, 2011
Urinary and sexual disorders following localised prostate cancer management - Abstract
February 16, 2011
Focal therapy in the management of localized prostate cancer - Abstract
February 16, 2011
Long-term outcome in patients with a Gleason score ≤ 6 prostate cancer treated by radical prostatectomy - Abstract
February 16, 2011
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens - Abstract
February 16, 2011
Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer - Abstract
February 16, 2011
Gleason 6 prostate cancer in one or two biopsy cores can harbor more aggressive disease - Abstract
February 16, 2011